Ji Wang - Jinhe Biotechnology Deputy Mang

002688 Stock   4.52  0.04  0.89%   

Executive

Ji Wang is Deputy Mang of Jinhe Biotechnology Co
Address 1-7-2 Building 27, Dalian, China, 116023
Webhttps://www.jinhe.com.cn

Jinhe Biotechnology Management Efficiency

The company has return on total asset (ROA) of 0.0223 % which means that it generated a profit of $0.0223 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0371 %, meaning that it generated $0.0371 on every $100 dollars invested by stockholders. Jinhe Biotechnology's management efficiency ratios could be used to measure how well Jinhe Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. At present, Jinhe Biotechnology's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 3.6 B, whereas Non Currrent Assets Other are forecasted to decline to about 58.5 M.

Similar Executives

Showing other executives

EXECUTIVE Age

Qiwei ZhaoXinjiang Baodi Mining
43
Rong ZhongChina World Trade
64
Gang XieGansu Huangtai Wine marketing
39
Hong OuyangState Grid InformationCommunica
57
Wu ShaoJCHX Mining Management
63
Xin JinChengtun Mining Group
42
Wei GaoXinjiang Baodi Mining
57
Bangfu WuJCHX Mining Management
53
Zhongping XuState Grid InformationCommunica
51
Linzhan GuoHarbin Air Conditioning
54
Nan LinChina World Trade
66
Hui SunState Grid InformationCommunica
48
Feng ChenChina World Trade
53
Jie ZhangState Grid InformationCommunica
46
Yongfang HeChina World Trade
N/A
Fanting JiChengtun Mining Group
48
Yang FengHarbin Air Conditioning
41
Wei DengState Grid InformationCommunica
47
Lele LuChengtun Mining Group
36
Pihong ZhangXinjiang Baodi Mining
42
Xuefeng ZhanHarbin Air Conditioning
54
Jinhe Biotechnology Co (002688) is traded on Shenzhen Stock Exchange in China and employs 2,316 people. Jinhe Biotechnology is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Jinhe Biotechnology Leadership Team

Elected by the shareholders, the Jinhe Biotechnology's board of directors comprises two types of representatives: Jinhe Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jinhe. The board's role is to monitor Jinhe Biotechnology's management team and ensure that shareholders' interests are well served. Jinhe Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jinhe Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ji Wang, Deputy Mang
Zhi Wang, Deputy Director
Changxian Xie, GM Director
Ying Liu, Deputy Manager
Manman Lu, Board Director
Yueqing Wang, Deputy Director
Yingzhen Guan, Deputy Manager
You Niu, Financial Director

Jinhe Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Jinhe Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Jinhe Stock

Jinhe Biotechnology financial ratios help investors to determine whether Jinhe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jinhe with respect to the benefits of owning Jinhe Biotechnology security.